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Background: We describe and evaluate the development and use of a Clinical Decision Support (CDS) intervention;
an alert, in response to an identified medical error of overuse of a diagnostic laboratory test in a Computerized
Physician Order Entry (CPOE) system. CPOE with embedded CDS has been shown to improve quality of care and
reduce medical errors. CPOE can also improve resource utilization through more appropriate use of laboratory tests
and diagnostic studies. Observational studies are necessary in order to understand how these technologies can be
successfully employed by healthcare providers.
Methods: The error was identified by the Test Utilization Committee (TUC) in September, 2008 when they noticed
critical care patients were being tested daily, and sometimes twice daily, for B-Type Natriuretic Peptide (BNP).
Repeat and/or serial BNP testing is inappropriate for guiding the management of heart failure and may be clinically
misleading. The CDS intervention consists of an expert rule that searches the system for a BNP lab value on the
patient. If there is a value and the value is within the current hospital stay, an advisory is displayed to the ordering
clinician. In order to isolate the impact of this intervention on unnecessary BNP testing we applied multiple
regression analysis to the sample of 41,306 patient admissions with at least one BNP test at LVHN between January,
2008 and September, 2011.
Results: Our regression results suggest the CDS intervention reduced BNP orders by 21% relative to the mean. The
financial impact of the rule was also significant. Multiplying by the direct supply cost of $28.04 per test, the
intervention saved approximately $92,000 per year.
Conclusions: The use of alerts has great positive potential to improve care, but should be used judiciously and in
the appropriate environment. While these savings may not be generalizable to other interventions, the experience
at LVHN suggests that appropriately designed and carefully implemented CDS interventions can have a substantial
impact on the efficiency of care provision.
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Computerized Physician Order Entry (CPOE) and embed-
ded Clinical Decision Support (CDS) have been shown to
improve quality of care and reduce medical errors [1-3].
CPOE and CDS can also improve resource utilization
through more appropriate use of laboratory tests and diag-
nostic studies. While a few Random-Controlled Trials
(RCTs) have addressed CDS and CPOE efficacy [2,4,5],
there are inherent limitations on the external validity of
such studies. As a result, observational studies are also ne-
cessary in order to understand how these technologies can
be successfully employed by healthcare providers. How-
ever, documentation of provider-initiated interventions is
often limited, and as a result, more studies of implementa-
tion at the point of care are needed to understand and
measure CDS and CPOE effectiveness [6,7].
We describe the development and use of a CDS inter-
vention in a CPOE system; an alert, in response to an ad-
ministratively identified medical error of overuse of a
diagnostic laboratory test. We discuss the complexity of
effective CPOE implementation and demonstrate the ben-
efits achieved by this quality improvement initiative
through a reduction in inappropriate testing and lower
medical care costs [2,7].
The medical error motivating this intervention was
identified by the Test Utilization Committee (TUC) at the
Lehigh Valley Health Network (LVHN), in Allentown, PA
on September, 2008. The TUC noticed critical care pa-
tients were being tested daily, and sometimes twice daily,
for B-Type Natriuretic Peptide (BNP). BNP is secreted by
the heart in response to changes in pressure that occur in
patients with congestive heart failure (CHF). It is used as a
marker to gauge the change in severity of CHF over time.
Repeat and/or serial BNP testing is inappropriate for guid-
ing the management of heart failure and may in fact be
clinically misleading [8]. Given that additional BNP tests
during an acute exacerbation of CHF provide no relevant
clinical information, it was initially unclear why so many
tests were being ordered. This overuse did not likely result
in adverse clinical events [9], but it did significantly in-
crease treatment costs.
All CDS interventions in response to identified errors
involve critical success factors such as a culture of ac-
ceptance of both technology and embedded ‘cognitive
forcing strategies” (rules and alerts, standardized order
sets, etc.) [10]. This report describes how one healthcare
system designed a targeted CDS intervention to reduce
unnecessary testing (and associated costs) in a CPOE
system, and evaluates its effectiveness. This intervention
was part of a larger initiative to create an “advanced”
[11] CDS environment capacity at LVHN. Advanced
CDS development moves beyond basic CPOE functions
to respond to identified medical errors, evidence-based
information changes, potential unintended consequencesand continuous quality improvement (CQI) over time,
benefiting from a supportive socio-technical infrastruc-
ture [11].
This study emerges from a growing body of literature
that seeks to rigorously evaluate applications of Health IT
in daily practice. A range of studies have focused on a
sociotechnical approach in order to evaluate the multiple
factors that contribute to effectiveness of these new tools
[12-14]. Factors that have contributed the use and ability
to evaluate decision support technologies include greater
emphasis by providers on knowledge-management, and
an increasing quantity of patient-specific data from genetic
testing and electronic health records [15]. The enhanced
ability of providers to analyze clinical practice patterns has
also contributed to studies seeking to define what consti-
tutes “appropriate testing” [16].
Among decision support tools, alerts and rules have
received a great deal of attention in the literature due to
the significant potential to improve care. CPOE systems
have been shown to reduce medical errors and overall
medical costs [1-3,17]. Several other studies and recent
review articles [2,3] generally support the potential of
CPOE and CDS to improve care, but note that most of
the evidence related to effectiveness of these tools is
from academic hospitals rather than community hospi-
tals and or primary care facilities. Alerts and rules have
also received a great deal of attention in the literature
due to identified barriers to their acceptance and imple-
mentation [14,18-21], and unintended consequences
[14,22-25]. For example, this CDS intervention, and the
development of the CPOE system in general, was designed
to minimize “alert fatigue” that may occur when clinicians
are overwhelmed by the number of alerts [21].
CPOE development and implementation
Lehigh Valley Health Network (LVHN) is the largest health
care provider in the Lehigh Valley region of Pennsylvania
with: three not-for-profit hospitals; nine health centers in
four counties; primary and specialty care practices
throughout the region; pharmacy, imaging and lab ser-
vices; and preferred provider services. In fiscal year 2012,
LVHN had over 54,000 acute admissions and 173,000
emergency department visits. The primary service area of
Lehigh, Northampton and Carbon counties has a com-
bined population of more than 800,000, making it
Pennsylvania’s third most populated region. Minorities
comprise more than 54% of all Allentown residents (the
region’s largest city), almost 43% of whom are Hispanic
or Latino.
LVHN’s Information Technology (IT) Department was
an early adopter of CPOE and CDS. The network has
been named one of the 100 Most Wired and 25 Most
Wireless hospitals by Hospitals and Health Networks
magazine. IT applications at LVHN are implemented
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input from providers and includes an evaluative compo-
nent pre and post implementation. Examples of this in-
frastructure include the Test Utilization Council (TUC)
that identified over-testing for BNP, and enterprise wide
Clinical Decision Support Committee, safety commit-
tees, and technology assessment groups. These groups
and committees maintain an ongoing sensitivity to work
flow issues in the implementation of CDS, including
just-in-time evidence-based decision support (clinical
knowledge) [15]. The discussion below demonstrates an
adaptation to overcome a socio-technical barrier to
effective usage of this technology—intrusion into the
physician work flow.
LVHN began implementation of CPOE in 2001; by
2006, all beds were converted and CPOE use was
mandatory. Concurrent with the implementation of CPOE
was the installation of a closed loop medication admi-
nistration system including embedded clinical decision
support, automated pharmacy robot dispensing, online
medication administration documentation and bar code
medication administration. At LVHN, the implementation
of this closed loop medication administration system is
estimated to have reduced potential harmful medication
errors by 80%. a
The initial approach to CDS at LVHN was very delib-
erate. The implementation team was acutely aware of
the impact that CPOE and CDS interventions had on
physician workflow as well as their potential for generat-
ing alert fatigue. Consequently, interventions that would
“add clicks” (such as alerts and rules) and standardized
order sets were added judiciously during the early stages
of the CPOE rollout—the “basic stage” [11]. As the phy-
sicians acclimated to the system, they became more re-
ceptive to an increasing number of CDS interventions.
Moving physicians along this “continuum of intrusion”
[26] was considered an important success factor by all
stakeholders for this CDS intervention.Figure 1 Screenshot of alert providing recent BNP
result information.Identification of BNP over-testing as a medical error
In September 2008, the Senior Clinical Pathologist no-
ticed critical care patients were being tested daily, and
sometimes twice daily, for B-type natriuretic Peptide
(BNP). The issue was brought to the TUC and priori-
tized as a high volume (and high cost) test requiring fur-
ther investigation and intervention. Research revealed
that repeat BNP testing is usually not indicated during a
hospital stay [8]. The TUC recommended modifying
LVHN’s existing CPOE system to employ an expert rule
to alert the ordering clinician that a BNP had been
performed during the current admission and that repeat
testing would add no value to the clinical decision mak-
ing process.Methods
CDS alert development
The CDS alert was implemented through an expert rule
that searches the system for a BNP lab value on the
patient. If there is a value and the value is within the
current hospital stay, an advisory is displayed to the
ordering clinician. (See Figure 1 for a screenshot of the
alert.) If there is no BNP lab value on the patient within
the current episode of care, the rule evaluates pending
orders for an active order for a BNP within the current
episode. If an active order is found, a different advisory
is displayed. If no lab value and no pending active order
exist in the current episode of care, then no advisory is
displayed. The alerts are advisory only and considered a
“soft stop” because the clinician still has the opportunity
to place the order after having been presented with rele-
vant information. The CDS intervention for repeat BNP
testing was implemented in June, 2009 and BNP order-
ing decreased by approximately 65% within six months
of introduction of the alert. Comparing the three month
period (January through March) before and after the
intervention indicates that total BNP ordering on in-
patient encounters decreased from 3,291 to 2,563, and
the number of patients receiving two or more BNP tests
during a single hospital stay decreased from 1,358 to 487
(p < .01). However, Figure 2 also reveals that there was a
downward trend in BNP testing during the surrounding
time period of the intervention. This trend could be the
result of several factors, including behavioral change on
the part of physicians or process changes caused by
other aspects of the new medication administration sys-
tem, as well as changes in the health and demographic
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Figure 2 Number of monthly inpatient BNP tests, January 2008 – November, 2009.
Table 1 Descriptive statistics for analysis variables
(N = 41,306)
Mean Min Max
BNP Orders 1.787 1 31
(SD = 1.364)
Age ≤ 40 0.022 0 1
40 < Age ≤ 60 0.146 0 1
60 < Age ≤ 80 0.432 0 1
Age > 80 0.399 0 1
Female 0.500 0 1
White 0.905 0 1
Black 0.023 0 1
Hispanic 0.024 0 1
Other race 0.048 0 1
Emergency admission 0.849 0 1
Elective admission 0.046 0 1
Urgent admission 0.103 0 1
DCG/HCC risk score 4.347 −0.875 17.779
(SD = 2.271)
Private insurance 0.132 0 1
Medicare 0.635 0 1
Medicaid 0.023 0 1
Self-pay 0.007 0 1
Private managed care 0.027 0 1
Medicare managed care 0.162 0 1
Medicaid managed care 0.014 0 1
Monthly time trend 21.659 1 45
(SD = 0.496)
Post intervention period 0.564 0 1
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In order to isolate the impact of the CPOE intervention
on unnecessary BNP testing, we apply multiple regres-
sion analysis to the sample of 41,306 patient admissions
with at least one BNP test at LVHN between January,
2008 and September, 2011. Although the average num-
ber of tests ordered was 1.8, the distribution of BNP or-
ders is skewed to the right with a maximum value of 31
(see Table 1). Therefore, we model the number of BNP
orders using a zero-truncated negative binomial (ZTNB)
distribution to account for both the truncation of the
dependent variable at 1, and the skewness of the distri-
bution [27].
We include a variety of controls in our models to ac-
count for changes over time in the characteristics of pa-
tients that may influence the propensity of physicians to
order additional tests. These include indicator variables
for patient age (age ≤ 40; 40 < age ≤ 60; 60 < age ≤ 80;
age > 80), gender, race (white; black; Hispanic; other
race), admission type (emergency; elective; urgent), and
insurance type (private traditional plan; Medicare; Me-
dicaid; self-pay; private managed care plan; Medicare
managed care; Medicaid managed care). In addition, we
include indicators for quartile of the inpatient cost risk
distribution, where risk is based on patients’ Diagnostic
Cost Group/Hierarchical Condition Category (DCG/HCC)
risk scores. b
Our intervention indicator is equal to 1 for all patient
admissions during or after June, 2009, the month that
the CPOE alert was put and place, and is equal to 0 be-
fore that date. The mean, minimum, and maximum of
the intervention indicator and all of the control variables
are listed in Table 1.
Table 2 Change in BNP orders associated with one unit
change in selected variables from ZTNB regression
(1) (2) (3)
40 < Age ≤ 60 0.125** 0.115** 0.114**
(0.055) (0.055) (0.056)
60 < Age ≤ 80 0.237*** 0.235*** 0.247***
(0.052) (0.052) (0.053)
Age > 80 0.315*** 0.310*** 0.326***
(0.055) (0.055) (0.057)
Female −0.005 −0.006 −0.006
(0.011) (0.011) (0.012)
Black −0.010 −0.012 −0.008
(0.040) (0.040) (0.041)
Hispanic −0.104*** −0.085** −0.010***
(0.035) (0.037) (0.036)
Other race 0.192*** 0.190*** 0.196***
(0.034) (0.034) (0.034)
Elective admission −0.094*** −0.085*** −0.089***
(0.028) (0.028) (0.028)
Urgent admission −0.005 0.003 0.007
(0.019) (0.019) (0.020)
1st risk score quartile −0.481*** −0.499*** −0.506***
(0.013) (0.014) (0.013)
2nd risk score quartile −0.322*** −0.337*** −0.338***
(0.013) (0.013)*** (0.013)
3rd risk score quartile −0.157*** −0.170*** −0.167***
(0.013) (0.013) (0.014)
Private insurance −0.031 −0.031 −0.024
(0.021) (0.021) (0.021)
Medicaid 0.088* 0.074 0.088*
(0.050) (0.048) (0.050)
Self-pay 0.051 0.051 0.034
(0.084) (0.086) (0.085)
Private managed care 0.002 0.002 0.013
(0.041) (0.041) (0.043)
Medicare managed care −0.030** −0.028* −0.030**
(0.015) (0.015) (0.015)
Medicaid managed care −0.001 −0.008 −0.002
(0.069) (0.061) (0.062)
Post intervention period −0.598*** −0.460*** −0.378***
(0.028) (0.030) (0.056)
Time trend variables
Monthly trend X X
Monthly trend squared X
Month indicators X
Notes: Standard errors in parenthesis; *** p<0.01, **p<0.05, *p<0.1. Base
categories include: age ≤ 40; white; emergency admission; 4th (highest) risk
score quartile; and Medicare.
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We estimate three ZTNB regression models in order to
test the sensitivity of our results to different specifica-
tions for capturing overall trends in BNP orders not due
to the intervention during the sample period. These re-
sults are reported in Table 2, which contains the mar-
ginal effects of the control variables and the intervention
indicator. The marginal effects are interpreted as the im-
pact on the number of BNP orders corresponding to a
one unit change in the given variable. The standard er-
rors of the marginal effects in parenthesis are robust to
heteroscedasticity.
In the first specification in column 1 we include a single
monthly time trend variable to capture aggregate trends in
BNP orders net of the CDS intervention. The estimates
from this specification suggest that the intervention re-
duced the number of BNP orders by 0.6 per inpatient ad-
mission, on average. However, when we include additional
variables to more flexibility control for aggregate trends
over time, this estimate is reduced by over 20%. In
addition to a linear monthly time trend, the specification
in column 2 also contains the square of the time trend,
while the specification in column 3 includes separate indi-
cator variables for each month of the sample. Among
these models, we prefer the third and most flexible specifi-
cation, which indicates that the intervention reduced the
number of BNP tests by 0.4 per admission. This effect is
precisely estimated, and represents a reduction in BNP or-
ders of 21% relative to the mean.
The financial impact of the rule was also significant. In
the three quarters prior to the implementation of the
intervention there were 11,209 BNP tests ordered at
LVHN. Based on our statistical model, we project that
the intervention reduced BNP orders by 21%, or 2,454
tests over three quarters. Multiplying by the direct sup-
ply cost of $28.04 per test, this suggests the intervention
saved approximately $92,000 per year. These savings are
based on supply cost only, and do not account for the
increased capacity for the laboratory to perform other
tests. As a result, the full annual long run benefits of the
intervention are greater than our estimate of supply cost
savings, after the short term costs of implementing the
intervention are recovered.
Discussion
While there are few observational studies that evaluate
the effectiveness of similar CDS interventions, Bates et
al [3]. found using a randomized controlled trial that
computerized reminders about redundant laboratory
tests significantly reduced the final number of ordered
tests. There is also a paucity of research on the impact
of CDS and CPOE on costs. A comprehensive 2010 re-
search review of the impact of CDS on test ordering and
appropriate utilization in the UK was not able to identify
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that reduced overuse of testing [4]. Nonetheless, the im-
portance of studies that determine the impact of CDS and
CPOE on cost is well recognized [2,4,7,11,28] A recent
meta analysis of the relatively small number of studies cur-
rently available that do address the cost consequences of
CPOE and CDS, found a significant amount of variability
in the level of cost savings; ranging from $6,000 to
$84,194 [29].
Much of the previous literature on CPOE addresses
the unintended consequences that result from the imple-
mentation of new technologies, the most serious of
which is e-iatrogenesis. Because there is no evidence that
this over-testing error caused harm to patients, it is not
an example of e-iatrogenesis. Furthermore, it is not clear
whether over-testing for BNP was in fact an unintended
consequence of CPOE. [22-25] In that case it may or
may not be classified as a “new kind of error” [24] or an
error made because of the existence of CPOE. LVHN
front line staff concluded that the over-testing occurred
because either the ordering physician did not understand
the time-period of the reliability of the test, or the phys-
ician was unable to find previous orders/ results in the
electronic record (or did not take the time to search the
system). If the former hypothesis is accurate then the ex-
perience of LVHN demonstrates the benefit of CPOE in
uncovering previously unrecognized instances of ineffi-
cient care, and the ability of complementary CDS tech-
nologies to increase the efficiency of care provision and
lower costs. In contrast, if the latter hypothesis is cor-
rect, LVHN’s experience demonstrates how CDS can be
used to correct an unintended consequence of CPOE .In
both cases the CDS intervention led to a positive out-
come, but the two underlying reasons for the over-use
error have very different implications for the efficacy of
CPOE. This highlights the need for future research stud-
ies that use a mix of qualitative and quantitative methods
to fully characterize and evaluate the use of new tech-
nologies [11-13,15]. Irrespective of the source of the
over-use error, LVHN’s method of identifying and
correcting the error can be replicated by other health
care networks with similar IT systems and socio-
technical infrastructures.
Conclusion
In the specific case of CDS, the use of alerts has great
potential to improve care, but should be used judiciously
and in the appropriate environment [11,14,20,26,30].
The intervention implemented at LVHN to reduce un-
necessary testing was effective because: 1) It alerted phy-
sicians that further BNP testing is potentially misleading;
2) It addressed an information failure associated with
the EMR (previous episode of care results were not vis-
ible once results were posted) and; 3) The interventionwas implemented and evaluated in the context of an ad-
vanced [11] CPOE system facilitating this cycle of imple-
mentation and evaluation. Although we cannot determine
how each of these factors independently contributed to the
success of the intervention, our statistical analysis indicates
that they collectively resulted in the reduction of BNP test-
ing by 21%; saving LVHN over $92,000 per year. While
these savings may not be generalizable to other interven-
tions, the experience at LVHN suggests that appropriately
designed and carefully implemented CDS interventions
can have a substantial impact on the efficiency of care
provision.
Endnotes
aLehigh Valley Health Network, Internal Report, 2011
bDCG/HCC risk scores are derived from data on pa-
tient age, sex, and physician-reported diagnosis codes
(ICD-9-CM). They have been validated as a proper
measure of risk adjustment in the inpatient setting (Ash
et al., 2003; Petersen, Pietz, Woodard & Byrne, 2005)
and are also used by CMS to risk adjust Medicare pay-
ments to private insurers under Part C (Pope et al.,
2004; Pope et al., 2000).
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